Certain types of university intellectual property can sometimes prove difficult to commercialise through traditional routes, usually because it is at an early stage of development, or because it presents enough uncertainty for companies to risk an investment.
University Technology’s Easy Access portal offers access to this type of intellectual property at no cost, to enable companies to evaluate it and put it to use quickly, with reduced risk.
Easy Access uses quick and simple licence agreements to fast-track the transfer of knowledge and expertise from Scotland’s universities to industry, so that these technologies may be developed for the benefit of the economy and society.
Through this initiative, our aim is to make it easier for Scottish universities and industry to work together and build strong, long-term relationships with industry partners.
Showing 11 - 20 of 46 opportunities
A novel approach shows promising results as a potential therapeutic for allergic conditions, including severe steroid resistant asthma. A peptide has been identified, HpARI, that inactivates and inhibits release of IL-33 a critical step in the development of allergic disease.
Novel compounds displaying high potency and selectivity toward SRC family kinases have been developed. The lead compound eCF506 displays subnanomolar potency against SRC, high selectivity over ABL kinase (1000-fold), optimal pharmacokinetic profile and in vivo target engagement.
Delirium is an acute and severe deterioration in mental function, which affects attention and cognition and poses a significant health problem for older patients in hospital. DelApp is a novel app based cognitive test, which can objectively detect delirium in patients.
This assay is a rapid and reproducible approach for epidemiological analysis of methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates. The assay identifies different strains on EMRSA-15, which is a major cause of hospital acquired MRSA infections in the UK and in other parts of the wo...
These genetic markers have an identified association with the individual prediction of susceptibility and severity of Paget's disease of the bone.
This anti-influenza therapy offers potential as anti-viral treatment as well as prevention against all major flu strains, including influenza A infection.
A host-directed diagnostic methodology, which uses only 30 μL of whole blood, and enables rapid and accurate detection of sepsis in neonates and other subjects. The test removes false negative results associated with current gold standard microbiological methods.
This range of novel synthetic polymers control bacterial attachment, resulting in specific sequestration or repulsion of bacteria such as Salmonella and E. coli.
These fully synthetic biocompatible polymers support effective human endothelial cell growth and endothelialisation, whilst minimising platelet attachment. The polymer materials can be applied as a thin coating to intra‐vascular devices and have the potential to minimise problems associated with vas...
This new approach converts chemotherapy agents into prodrugs, significantly reducing systemic toxicity, and enabling local activation only at tumour sites where a specific catalyst, palladium, has been implanted.
Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities